Are Magic Mushrooms Legal in Canada? Laws and Regulations for 2024

Wondering about the legal status of magic mushrooms in Canada? You’re not the only one. With growing interest in their potential health benefits and alternative therapies, many people are curious about the laws in 2024. Understanding the guidelines for using, possessing, and distributing magic mushrooms can be complex.

In this article, we’ll break down the current laws, highlight the latest updates, and provide you with the information you need to stay informed and confident. Whether you’re considering magic mushrooms for personal use or professional purposes, we’ve got you covered. By the end, you’ll have a clear understanding of the legal landscape and what you need to know moving forward.

About Magic Mushrooms

Magic mushrooms, often called shrooms, are a type of fungi that can cause powerful mind-altering effects. The most common type is called Psilocybe cubensis, but there are many other similar species. These mushrooms contain two main active ingredients: psilocybin and psilocin.

When you consume magic mushrooms, your body converts psilocybin into psilocin, which is what actually causes the psychedelic effects. These effects can include changes in how you perceive time, enhanced senses, vivid colors and sounds, and deep changes in thoughts and feelings. People use magic mushrooms for various reasons, including recreation, spiritual experiences, and even therapy.

Magic mushrooms have been used for thousands of years by indigenous cultures for spiritual and healing purposes. Nowadays, there’s a lot of interest in their potential to help with mental health issues like depression, anxiety, and PTSD.

It’s important to understand both the science and the laws around magic mushrooms if you’re thinking about using them. This way, you can make informed decisions about your health and well-being.

Short-term Effects of Magic Mushrooms

After eating magic mushrooms, get ready for a wild ride! Within about 20 to 60 minutes, you might start to experience some unique and interesting sensations. Colors might appear more vibrant, sounds might become more pronounced, and you might even notice fascinating visual effects, such as patterns shifting on the walls or imaginative shapes in the clouds.

Your emotions could go on a rollercoaster, swinging from super happy to a little scared or anxious. But don’t worry, that’s all part of the trip! Your brain might start thinking in new and creative ways, giving you deep thoughts or big ideas you’ve never considered before. Time might feel like it’s stretching out or even standing still, and your body might feel funny sensations, like tingling or warmth. Just remember, everyone’s journey is different, so buckle up and enjoy the adventure!

Mental Effects

During a magic mushroom trip, get ready for a whirlwind of mental adventures! Your thoughts might take you to places you’ve never been before, like a rocket ship soaring through space.

You might see the world in a whole new light, with colors popping and everything feeling more alive than ever. It’s like your brain is throwing a party, with creativity as the guest of honor! You might have deep insights into yourself and the universe, feeling like you’re uncovering secrets that have been hiding in plain sight.

But don’t be surprised if things get a little wacky—after all, it’s all part of the fun! Just sit back, relax, and let your mind take you on the journey of a lifetime.

Physical Effects

During a magic mushroom trip, you might experience various physical effects. These can include changes in sensory perception, such as heightened sensitivity to colors, sounds, and textures. 

You might also feel sensations like tingling or warmth spreading through your body, or a feeling of lightness or heaviness. Some people may experience mild nausea or stomach discomfort, especially during the onset of the trip, but this usually subsides as the experience progresses. 

It’s important to stay hydrated and comfortable during the trip, as well as to be in a safe and supportive environment. Overall, the physical effects of a magic mushroom trip can vary from person to person and from one trip to another.

Long-term Effects of Magic Mushrooms

When it comes to magic mushroom use, most of the focus is on the short-term journey, but what about the long-term effects? Well, the good news is that research suggests magic mushrooms are generally considered safe when used responsibly. 

However, there are some potential long-term considerations. While there isn’t much evidence to suggest that occasional or moderate use of magic mushrooms leads to long-term harm, heavy or frequent use could have some risks.

Overall, like with any substance, moderation and mindfulness are key to minimizing potential long-term effects and maximizing the benefits of magic mushroom use.

Risks Related to Use of Magic Mushrooms

When considering magic mushroom use, it’s crucial to understand the potential risks and safety factors involved.

Firstly, magic mushrooms can significantly enhance your thoughts, feelings, and perceptions, potentially leading to profound experiences. If you have a history of mental health issues, it’s important to be mindful of their potential impact. While there’s a chance of encountering a challenging experience, often called a “bad trip,” characterized by intense emotions or confusion, you can greatly reduce this risk by ensuring you are in a safe and supportive environment with trusted friends. This preparation can help foster a more positive and enriching journey.

Physically, while magic mushrooms are generally considered safe, they can induce effects like nausea, vomiting, and increased heart rate, especially during the onset of the trip. Staying hydrated and looking after your body can help alleviate these effects.

Moreover, it’s essential to be aware of the legal status of magic mushrooms in your area, as they are classified as illegal substances in many places. Understanding the laws and potential consequences of possession or use is crucial to staying safe and compliant.

Lastly, the environment and your mindset leading up to the experience play significant roles in shaping the trip. Being in a comfortable, familiar setting with people you trust can enhance the experience and reduce the likelihood of negative outcomes. By being mindful of these risks and safety considerations, you can approach magic mushroom use with respect and responsibility.

Substance Use Disorders and Withdrawal

It’s essential to be aware that while magic mushrooms are not typically associated with physical dependence or withdrawal symptoms like some other substances, there is still a potential risk of developing a substance use disorder (SUD). 

Some people might find themselves using magic mushrooms more frequently or in higher doses than they initially intended. To ensure a safe and positive experience, it’s important to stay mindful of usage and set clear intentions, helping to maintain balance and well-being in all areas of life.

Additionally, some individuals may find themselves relying on magic mushrooms to cope with stress or other challenges. To ensure a positive experience, it’s beneficial to use them mindfully and seek a balanced approach to managing life’s pressures. This can help maintain control and harmony in daily life.

While the risk of developing a SUD with magic mushrooms may be lower compared to substances like alcohol or opioids, it’s still essential to use them responsibly and be mindful of your usage patterns and motivations. 

Seeking support from friends, family, or professionals if you’re concerned about your magic mushroom use is always a good idea. Remember, staying informed and making informed choices is key to staying safe and healthy.

Potential Therapeutic Uses of Psilocybin

Psilocybin, found in magic mushrooms, has been gaining attention for its potential therapeutic effects. Research suggests that psilocybin may offer promising benefits for mental health conditions like depression, anxiety, and PTSD. One of its most notable qualities is its ability to induce profound and mystical experiences, which some studies suggest can lead to lasting improvements in mood, outlook on life, and overall well-being.

For individuals struggling with depression, psilocybin therapy has shown promise in providing relief when other treatments have failed. It’s thought to work by disrupting rigid thought patterns and promoting new perspectives, allowing individuals to break free from negative thought cycles and find new ways of thinking about themselves and their lives.

Similarly, psilocybin therapy has shown potential in treating anxiety, particularly in individuals facing life-threatening illnesses or existential distress. The experience of ego dissolution and a sense of interconnectedness with others and the universe during a psilocybin trip may help individuals confront existential fears and find peace and acceptance.

For those suffering from PTSD, psilocybin therapy holds promise in helping individuals process and integrate traumatic memories in a safe and supportive environment. The heightened emotional openness and sense of connection experienced during a psilocybin session may facilitate breakthroughs in therapy and lead to significant reductions in PTSD symptoms.

It’s important to note that while the research is promising, psilocybin therapy is still in its early stages, and more studies are needed to fully understand its therapeutic potential and establish safe and effective treatment protocols,

Access to Psilocybin for Therapeutic Use

Accessing psilocybin for therapeutic purposes in Canada, including the Ontario region, involves several pathways, both legal and medical. 

Clinical Trials with Psilocybin

There are several ongoing and completed clinical trials with magic mushrooms that have highlighted the needs and benefits of using magic mushrooms.

Ongoing Trials:

Treatment-Resistant Depression: Multiple ongoing trials are investigating the use of psilocybin-assisted therapy for treatment-resistant depression. These trials aim to assess the safety and efficacy of psilocybin in combination with therapy for individuals who have not responded to conventional antidepressant medications.

Anxiety Disorders: Some ongoing trials are exploring the potential of psilocybin-assisted therapy in treating various anxiety disorders, including generalized anxiety disorder (GAD), social anxiety disorder (SAD), and existential anxiety in patients facing life-threatening illnesses.

Substance Use Disorders: There are ongoing trials investigating the use of psilocybin-assisted therapy for substance use disorders, such as alcohol dependence, nicotine addiction, and opioid use disorder. These trials aim to evaluate the feasibility and effectiveness of using psilocybin to address underlying psychological factors contributing to substance misuse.

End-of-Life Anxiety: Psilocybin-assisted therapy is being studied in ongoing trials as a potential treatment for end-of-life anxiety in patients with terminal illnesses. These trials aim to assess the psychological and existential effects of psilocybin therapy on patients’ quality of life and attitudes toward death.

Completed Trials:

Pilot Studies

Several pilot studies and early-phase trials have been completed to assess the safety, feasibility, and preliminary efficacy of psilocybin-assisted therapy for various mental health conditions, including depression, anxiety, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD).

Longitudinal Studies

 Some completed trials have followed participants over an extended period to investigate the long-term effects of psilocybin therapy on mental health outcomes, quality of life, and behavior change.

Brain Imaging Studies

 Completed trials have also utilized neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), to investigate the neural mechanisms underlying the therapeutic effects of psilocybin and its impact on brain function and connectivity.

These clinical trials are conducted by research institutions, universities, and organizations worldwide and are designed to provide scientific evidence supporting the therapeutic potential of psilocybin in various clinical contexts. It’s essential to note that the results of these trials may vary, and further research is needed to establish the safety and efficacy of psilocybin therapy across different populations and conditions.

Health Canada’s Special Access Program

Health Canada’s Special Access Program (SAP) provides a pathway for healthcare practitioners to request access to drugs that are not otherwise available for sale in Canada but may be needed to treat patients with serious or life-threatening conditions. This program allows healthcare providers to request access to drugs on behalf of their patients when conventional treatments have been ineffective, unsuitable, or unavailable.

For psilocybin specifically, healthcare practitioners in Canada can submit a request to Health Canada through the SAP for access to psilocybin for therapeutic purposes. This request must include information about the patient’s medical condition, previous treatments, and the rationale for considering psilocybin therapy as a potential treatment option. Health Canada evaluates each request on a case-by-case basis, taking into account the patient’s medical history, the supporting evidence for psilocybin therapy, and considerations of safety and efficacy.

If Health Canada approves the request, the healthcare provider can then obtain psilocybin from authorized suppliers and administer it to the patient under appropriate medical supervision. It’s important to note that access to psilocybin through the SAP is typically reserved for exceptional cases where other treatment options have been exhausted, and there is sufficient evidence to support the use of psilocybin for the specific medical condition.

Health Canada’s Special Access Program provides a regulatory framework that allows for access to psilocybin for therapeutic purposes in certain circumstances while ensuring appropriate oversight and monitoring to safeguard patient safety. Access to psilocybin through the SAP is subject to strict regulatory requirements and is intended to be used judiciously by healthcare practitioners in collaboration with their patients to provide compassionate care for individuals with serious medical needs.

Related Links

1. Simultaneous Production of Psilocybin and a Cocktail of β‐Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms: This research investigates the secondary metabolites in magic mushrooms that contribute to their psychotropic effects (Blei et al., 2019).

2. Production Options for Psilocybin: Making of the Magic: This paper highlights the biosynthesis, production methods, and therapeutic relevance of psilocybin (Fricke et al., 2018).

3. Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes: This study evaluates the effects and safety of magic mushroom extracts in cardiac cells (Nkadimeng et al., 2020).

4. Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication: A case report detailing the symptoms and treatment of a patient with Psilocybe cubensis intoxication (Kusumadewi, 2020).

5. Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom: This paper investigates the antioxidant and anti-inflammatory properties of Psilocybe natalensis (Nkadimeng et al., 2020).

6. An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus: A comprehensive review on the taxonomy and ecology of psychedelic mushrooms (Strauss et al., 2022).

Page Details

As of last update of this page on 1 june 2024, this was the legal status of the laws regarding magic mushrooms in Canada.

Share This Page

If you found this article helpful and informative, please consider sharing it on your social media platforms or with friends and family who might benefit from understanding the legal status of magic mushrooms in Canada.

Spreading accurate information can help raise awareness and contribute to informed discussions on this important topic. Sharing this article can also support those seeking legal pathways for therapeutic use and help highlight ongoing research and developments in the field.

Let’s work together to promote knowledge and responsible use of psychedelics by sharing this valuable resource!

About This Site

Elevated You is a leading online resource in Canada, dedicated to providing high-quality magic mushrooms and other psychedelic products

This website aims to promote mental wellness through alternative medicine, offering a wide range of products including dried mushrooms, shroom teas, and microdoses. Elevated You is committed to ensuring safe access and discretion for its customers, providing fast delivery across all provinces and territories in Canada.

We pride ourselves  on the quality of our products, all of which undergo rigorous testing to meet the highest standards of safety and efficacy. For more information, you can visit Elevated You.

Health Canada

Health Canada regulates the use of magic mushrooms (psilocybin) under the Controlled Drugs and Substances Act, where psilocybin is classified as a Schedule III controlled substance, making its general production, sale, and possession illegal. However, Health Canada provides legal pathways for therapeutic use through clinical trials, the Special Access Program, and Section 56 exemptions for medical or scientific purposes. These pathways ensure the safety, efficacy, and quality of psilocybin products used for medical purposes. Health Canada’s involvement emphasizes rigorous oversight and regulatory compliance to protect public health while facilitating research into the potential therapeutic benefits of psilocybin. For more details, visit Health Canada’s page on psilocybin. 

​Government of Canada

The Government of Canada’s stance on magic mushrooms has evolved significantly over the years, primarily in response to growing interest in their potential therapeutic uses. Magic mushrooms, which contain the psychoactive compound psilocybin, have long been classified as a Schedule III controlled substance under the Controlled Drugs and Substances Act (CDSA), making their production, possession, and distribution illegal except for authorized medical, scientific, or industrial purposes. 

In recent years, research into the therapeutic benefits of psilocybin has gained momentum. This led to Health Canada amending the Special Access Program (SAP) in January 2022, allowing healthcare professionals to request access to psilocybin for patients with serious or life-threatening conditions where conventional treatments have failed, are unsuitable, or unavailable.

This amendment marked a significant shift, providing a legal pathway for the use of psilocybin in a controlled and supervised setting, highlighting the government’s willingness to support medical research while maintaining strict regulatory controls. 

Additionally, researchers can apply for exemptions under the CDSA to conduct clinical trials involving psilocybin, further supporting scientific investigation into its potential benefits. This regulatory framework underscores Canada’s balanced approach, aiming to ensure both public safety and the advancement of medical science.

Themes and Topics

This article covers the history and effects of magic mushrooms, both short-term and long-term, and addresses the potential risks associated with their use, such as psychological and physical effects, substance use disorders, and withdrawal. 

The article highlights the potential therapeutic uses of psilocybin, especially for mental health conditions like depression, anxiety, and PTSD, and explains how individuals can access psilocybin for therapeutic purposes through clinical trials and Health Canada’s Special Access Program. 

The discussion includes ongoing and completed clinical trials, as well as the roles of Health Canada and the Government of Canada in regulating psilocybin use. 

Government of Canada Corporate

In Canada, the government considers psilocybin, the substance in magic mushrooms, a controlled substance.

However, Health Canada’s Special Access Program offers a way for doctors to access psilocybin for patients with serious health issues when other treatments don’t work. Researchers can also apply for exemptions to study psilocybin in clinical trials. While provinces may have their own rules, federal law mainly determines how magic mushrooms are regulated in Canada.